PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor

Kelly Airiau(Université de Bordeaux), Françis Belloc(Université de Bordeaux)

Cell Death and Disease

October 3, 2013

10.1038/cddis.2013.309

Cited by 67

Related Papers

Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells

|Experimental Hematology|2008|37

Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells

|Oncotarget|2015|21

TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex

|Cells|2021|9